Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

618
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
618
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

204
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
204
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
Hypersensitivities01:30

Hypersensitivities

1.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atopic Dermatitis Across the Lifespan: Understanding, Measuring and Minimizing Cumulative Life Course Impairment.

Acta dermato-venereologica·2026
Same author

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

The Journal of dermatological treatment·2026
Same author

ProtekDuo in Lung Transplant Candidates: Insights From a Single-Center Study of Cases.

Annals of thoracic surgery short reports·2026
Same author

Raising the bar of efficacy in Atopic Dermatitis: deep response in week 16 responders treated with lebrikizumab over 2 years.

The Journal of dermatological treatment·2026
Same author

Development of a Patient Decision Aid for Atopic Dermatitis Systemic Treatments in Adults.

JAMA dermatology·2026
Same author

Primary Cutaneous Cribriform Apocrine Carcinoma: A Case Report and Narrative Review.

BioMed (Basel, Switzerland)·2026
Same journal

Innovations and Emerging Therapies in Atopic Dermatitis Part 2.

Current treatment options in allergy·2025
Same journal

Drug-Induced Kounis Syndrome: Latest Novelties.

Current treatment options in allergy·2023
Same journal

Updates and Recent Advances on Venom Immunotherapy.

Current treatment options in allergy·2023
Same journal

Dance Is a Healing Art.

Current treatment options in allergy·2023
Same journal

New Biomarkers in Anaphylaxis (Beyond Tryptase).

Current treatment options in allergy·2022
Same journal

New Challenges in Drug Allergy: the Resurgence of Excipients.

Current treatment options in allergy·2022
See all related articles

Related Experiment Video

Updated: Sep 18, 2025

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

916

Innovations and Emerging Therapies in Atopic Dermatitis Part 1.

Robyn Okereke1, Eric Simpson1

  • 1Department of Dermatology, Oregon Health and Sciences University, 3303 S Bond Ave Building 1, 16th Floor, Portland, OR 97239, USA.

Current Treatment Options in Allergy
|June 23, 2025
PubMed
Summary
This summary is machine-generated.

New systemic therapies for atopic dermatitis (AD) offer improved efficacy and safety over broad immunosuppression. Future research should focus on optimizing these targeted treatments for long-term use.

Keywords:
Atopic DermatitisBiologicsEmerging therapyInnovationsSmall moleculesSystemic therapy

More Related Videos

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

9.8K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.3K

Related Experiment Videos

Last Updated: Sep 18, 2025

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

916
Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

9.8K
Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.3K

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • The treatment of atopic dermatitis (AD) is rapidly evolving.
  • Current therapeutic strategies are shifting from general immune suppression to targeted molecular therapies.

Purpose of the Study:

  • To review innovative systemic therapies for atopic dermatitis.
  • To compare emerging and current systemic treatment options.
  • To highlight novelties in systemic AD treatment (Part 1 of a two-part series).

Main Methods:

  • Literature review of recent advancements in atopic dermatitis systemic therapies.
  • Comparative analysis of targeted molecular therapies versus traditional systemic treatments.
  • Evaluation of efficacy and safety data from clinical studies and real-world evidence.

Main Results:

  • The shift towards targeted molecular therapies in AD shows promise for enhanced efficacy and safety.
  • Systemic therapies demonstrate a superior profile compared to broad anti-inflammatory approaches.
  • Shortcomings in long-term efficacy and real-world data for systemic therapies require further investigation.

Conclusions:

  • Recent advances in systemic therapies represent a significant paradigm shift in atopic dermatitis management.
  • While promising, further studies are necessary to optimize the formulations and real-world performance of these treatments.
  • Future research should address long-term outcomes and safety profiles for systemic atopic dermatitis therapies.